Medicine and Dentistry
Injection
100%
Bevacizumab
100%
Intravitreal Administration
100%
Pharmacokinetics
100%
Pars Plana
100%
Tissues
50%
Laboratory
33%
Specimen
16%
Analysis
16%
Immune Response
16%
Drug
16%
Chemotherapeutic Agent
16%
Retina
16%
Histology
16%
Sustained Drug Release
16%
Tissue Reaction
16%
Drug Distribution
16%
Choroid
16%
Granulomatosis
16%
Retinal Pigment Epithelium
16%
Photoreceptor Outer Segment
16%
Immunohistology
16%
Granulomatous Vasculitis
16%
Biological Molecule
16%
Inflammation
16%
Nursing and Health Professions
Injection
100%
Intravitreal Drug Administration
100%
Bevacizumab
100%
Laboratory
33%
Dose
33%
Tissue Level
33%
Histology
16%
Analysis
16%
Drug
16%
Inflammation
16%
Visual Pigment
16%
Drug Tissue Level
16%
Tissue Reaction
16%
Immunohistology
16%
Intraocular Drug Administration
16%
Granulomatous Vasculitis
16%
Sustained Release Formulation
16%
Granulomatosis
16%